search
Back to results

Identification of Undiagnosed Gaucher Disease

Primary Purpose

Gaucher Disease

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Enzyme analysis
Sponsored by
Brigham and Women's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Gaucher Disease focused on measuring Gaucher disease, lysosomal storage disorder, metabolic disease, medical records review

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Must have records available in the Partners HealthCare Patient Data Registry

Exclusion Criteria:

  • Must not have a diagnosis of Gaucher disease

Sites / Locations

  • Brigham and Women's Hosptial

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Enzyme analysis

Arm Description

Patients invited for evaluation will undergo glucocerebrosidase enzyme analysis

Outcomes

Primary Outcome Measures

number of patients with previously undiagnosed GD identified

Secondary Outcome Measures

Full Information

First Posted
October 26, 2012
Last Updated
October 26, 2012
Sponsor
Brigham and Women's Hospital
Collaborators
Genzyme, a Sanofi Company
search

1. Study Identification

Unique Protocol Identification Number
NCT01716741
Brief Title
Identification of Undiagnosed Gaucher Disease
Official Title
Identification of Undiagnosed Gaucher Disease
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Unknown status
Study Start Date
August 2012 (undefined)
Primary Completion Date
August 2014 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital
Collaborators
Genzyme, a Sanofi Company

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Partners HealthCare maintains a Patient Data Registry (PDR) with information from all patient encounters at Partners HealthCare facilities. We intend to utilize the PDR to identify groups of patient who are of high clinical suspicion for undiagnosed Gaucher disease. A group of potential participants will be identified through the PDR. Detailed records will be requested to further narrow to ideal participants based upon previously existing diagnoses and symptoms. Participants will be invited to partake in the study via a letter from their Partners care provider with supporting study details. Study participants will be evaluated in a one-time visit. A complete family and medical history will be collected. A physical exam will be performed, and up to 20cc of blood will be drawn. All participants will be notified of their disease status via letter and phone call from the study staff. If the study participant is diagnosed with GD through this evaluation, proper follow-up recommendations and referrals will be provided. Our intent is to determine if existing patient data can successfully be utilized to aid in the identification of patients with rare genetic disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gaucher Disease
Keywords
Gaucher disease, lysosomal storage disorder, metabolic disease, medical records review

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Enzyme analysis
Arm Type
Other
Arm Description
Patients invited for evaluation will undergo glucocerebrosidase enzyme analysis
Intervention Type
Other
Intervention Name(s)
Enzyme analysis
Primary Outcome Measure Information:
Title
number of patients with previously undiagnosed GD identified
Time Frame
up to 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must have records available in the Partners HealthCare Patient Data Registry Exclusion Criteria: Must not have a diagnosis of Gaucher disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael F Murray, MD
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Hosptial
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Identification of Undiagnosed Gaucher Disease

We'll reach out to this number within 24 hrs